Recombinant BAF53B Monoclonal Antibody (AN302040L)
For research use only.
| Verified Samples | Verified Samples in WB: HeLa,?K562, Neuro-2a, PC-12 |
| Dilution | WB 1:5000 |
| Isotype | IgG, κ |
| Host | Rabbit |
| Reactivity | Human, Rat, Mouse |
| Applications | WB |
| Clonality | Monoclonal;Recombinant |
| Immunogen | Peptide. This information is proprietary to PTMab. |
| Abbre | BAF53B |
| Synonyms | ACTL, ACTL6, BAF53B, ACTL6B, 53 kDa BRG1 associated factor B, 53 kDa BRG1-associated factor B, ACL 6B, ACL6B, Actin like 6, Actin like protein 6B, Actin like protein6B, Actin related protein, Actin related protein Baf53b, actin-like 6B, Actin-like protein 6B, Actin-related protein Baf53b, Actl 6, ACTL 6B, ACTL6 B, Arp Na, ArpN a, ArpN alpha, ArpNa, ArpNalpha, Baf 53b, BRG1-associated factor 53B |
| Swissprot | |
| Calculated MW | 47 kDa |
| Observed MW |
47 kDa
Western blotting is a method for detecting a certain protein in a complex sample based on the specific binding of antigen and antibody. Different proteins can be divided into bands based on different mobility rates. The mobility is affected by many factors, which may cause the observed band size to be inconsistent with the expected size. The common factors include: 1. Post-translational modifications: For example, modifications such as glycosylation, phosphorylation, methylation, and acetylation will increase the molecular weight of the protein. 2. Splicing variants: Different expression patterns of various mRNA splicing bodies may produce proteins of different sizes. 3. Post-translational cleavage: Many proteins are first synthesized into precursor proteins and then cleaved to form active forms, such as COL1A1. 4. Relative charge: the composition of amino acids (the proportion of charged amino acids and uncharged amino acids). 5. Formation of multimers: For example, in protein dimer, strong interactions between proteins can cause the bands to be larger. However, the use of reducing conditions can usually avoid the formation of multimers. If a protein in a sample has different modified forms at the same time, multiple bands may be detected on the membrane. |
| Cellular Localization | Nucleus |
| Concentration | 1 mg/mL |
| Buffer | PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant. |
| Purification Method | Protein A purified |
| Research Areas | Neuroscience, Epigenetics and Nuclear Signaling, Stem Cells |
| Clone No. | A760 |
| Conjugation | Unconjugated |
| Storage | Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles. |
| Shipping | Ice bag |
| background | BAF53/ACTL6 proteins are highly homologous, actin-related proteins found in the SWI/SNF complex. In addition to the canonical SWI/SNF complex, BAF53A/ACTL6A is also member of the embryonic SWI/SNF complex, known as esBAF, which plays a role in pluripotency and development. BAF53B/ACTL6B is a member of the neural-specific SWI/SNF complex that facilitates binding to target genes and is involved in memory and synaptic plasticity. BAF53/ACTL6 has been shown to interact with c-Myc, where it functions as a cofactor and is important in the transformation process. Further studies have shown ACTL6/BAF53 is associated with EMT and transformation in various cancers. |
Other Clones
{{antibodyDetailsPage.numTotal}} Results
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
Other Formats
{{formatDetailsPage.numTotal}} Results
Unconjugated
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
-
IF：{{item.impact}}
Journal：{{item.journal}} ({{item.year}})
DOI：{{item.doi}}Reactivity：{{item.species}}
Sample Type：{{item.organization}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
